Nanoparticle-based inner ear delivery systems for the treatment of hearing loss

Xiaoyu Xu, Shengyi Wang, Yilai Shu, Hongbo Zhang*

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

8 Citations (Scopus)
47 Downloads (Pure)


Hearing loss has become the most common sensory disorder worldwide. Despite intensive research on the pathophysiology of hearing loss, biological therapeutic approaches are limited by the anatomical and physiological characteristics of the inner ear. Challenges in inner ear drug delivery involve biotherapeutic instability, membrane inaccessibility and delivery non-specificity. With the development of nanotechnology, the nanoparticle-based delivery systems are promising to overcome these limitations. After drugs loading and stabilization, nanoparticles can carry the drugs into the inner ear by crossing round window membrane. The surface bioconjugation of ligand endows nanoparticles with specific targeting capability. Nanoparticles with stimuli-responsive moieties can provide a controlled release manner. Together, these strategies show great potential for hearing loss treatment. Understanding the current advances of nanotechnology in hearing loss treatment will facilitate future therapeutic options and clinical applications.

Original languageEnglish
Pages (from-to)350-353
JournalSmart Materials in Medicine
Publication statusPublished - Nov 2021
MoE publication typeA1 Journal article-refereed


Dive into the research topics of 'Nanoparticle-based inner ear delivery systems for the treatment of hearing loss'. Together they form a unique fingerprint.

Cite this